74 related articles for article (PubMed ID: 17032447)
1. Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome.
Mylona E; Magkou C; Giannopoulou I; Agrogiannis G; Markaki S; Keramopoulos A; Nakopoulou L
Breast Cancer Res; 2006; 8(5):R57. PubMed ID: 17032447
[TBL] [Abstract][Full Text] [Related]
2. The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.
Nakopoulou L; Lazaris AC; Panayotopoulou EG; Giannopoulou I; Givalos N; Markaki S; Keramopoulos A
J Clin Pathol; 2004 May; 57(5):523-8. PubMed ID: 15113861
[TBL] [Abstract][Full Text] [Related]
3. Prognostic biomarkers and molecular pathways mediating Helicobacter pylori-induced gastric cancer: a network-biology approach.
Kamarehei F; Saidijam M; Taherkhani A
Genomics Inform; 2023 Mar; 21(1):e8. PubMed ID: 37037466
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma.
Huang M; Zhang T; Yao ZY; Xing C; Wu Q; Liu YW; Xing XL
BMC Med Genomics; 2021 Mar; 14(1):72. PubMed ID: 33750388
[TBL] [Abstract][Full Text] [Related]
5. CircFNDC3B sequestrates miR-937-5p to derepress TIMP3 and inhibit colorectal cancer progression.
Zeng W; Liu Y; Li WT; Li Y; Zhu JF
Mol Oncol; 2020 Nov; 14(11):2960-2984. PubMed ID: 32896063
[TBL] [Abstract][Full Text] [Related]
6. MAb NJ001 inhibits lung adenocarcinoma invasiveness by directly regulating TIMP-3 promoter activity via FOXP1 binding sites.
Gu C; Luo Y; Zhang S; Xu J; Zhang J; Ju H; Liu J; Zhang L; Zhang Y; Wu L; Xie E; Xu T; Pan S
Thorac Cancer; 2020 Sep; 11(9):2630-2638. PubMed ID: 32744429
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process.
González-González A; González A; Rueda N; Alonso-González C; Menéndez JM; Martínez-Campa C; Mitola S; Cos S
Sci Rep; 2020 Mar; 10(1):4790. PubMed ID: 32179814
[TBL] [Abstract][Full Text] [Related]
8. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study.
Olivares-Urbano MA; Griñán-Lisón C; Zurita M; Del Moral R; Ríos-Arrabal S; Artacho-Cordón F; Arrebola JP; González AR; León J; Antonio Marchal J; Núñez MI
J Cell Mol Med; 2020 Jan; 24(1):139-148. PubMed ID: 31568637
[TBL] [Abstract][Full Text] [Related]
10. TIMP3 Promoter Methylation Represents an Epigenetic Marker of BRCA1ness Breast Cancer Tumours.
Maleva Kostovska I; Jakimovska M; Popovska-Jankovic K; Kubelka-Sabit K; Karagjozov M; Plaseska-Karanfilska D
Pathol Oncol Res; 2018 Oct; 24(4):937-940. PubMed ID: 29524167
[TBL] [Abstract][Full Text] [Related]
11. Differential Impact of Flavonoids on Redox Modulation, Bioenergetics, and Cell Signaling in Normal and Tumor Cells: A Comprehensive Review.
Kerimi A; Williamson G
Antioxid Redox Signal; 2018 Dec; 29(16):1633-1659. PubMed ID: 28826224
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells.
Fontanil T; Álvarez-Teijeiro S; Villaronga MÁ; Mohamedi Y; Solares L; Moncada-Pazos A; Vega JA; García-Suárez O; Pérez-Basterrechea M; García-Pedrero JM; Obaya AJ; Cal S
Oncotarget; 2017 Feb; 8(8):13716-13729. PubMed ID: 28099917
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms and Metabolomics of Natural Polyphenols Interfering with Breast Cancer Metastasis.
Ci Y; Qiao J; Han M
Molecules; 2016 Dec; 21(12):. PubMed ID: 27999314
[TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism.
Qi JH; Anand-Apte B
Apoptosis; 2015 Apr; 20(4):523-34. PubMed ID: 25558000
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.
Kim GE; Lee JS; Choi YD; Lee KH; Lee JH; Nam JH; Choi C; Kim SS; Park MH; Yoon JH; Kweon SS
BMC Cancer; 2014 Dec; 14():959. PubMed ID: 25510449
[TBL] [Abstract][Full Text] [Related]
16. Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors.
Roy DM; Walsh LA
Breast Cancer (Dove Med Press); 2014; 6():81-91. PubMed ID: 25114586
[TBL] [Abstract][Full Text] [Related]
17. Higher miR-21 expression in invasive breast carcinomas is associated with positive estrogen and progesterone receptor status in patients from Serbia.
Petrović N; Mandušić V; Dimitrijević B; Roganović J; Lukić S; Todorović L; Stanojević B
Med Oncol; 2014 Jun; 31(6):977. PubMed ID: 24781337
[TBL] [Abstract][Full Text] [Related]
18. The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion.
Petrović N; Mandušić V; Stanojević B; Lukić S; Todorović L; Roganović J; Dimitrijević B
Med Oncol; 2014 Mar; 31(3):867. PubMed ID: 24488617
[TBL] [Abstract][Full Text] [Related]
19. Expression of MMP-3 and TIMP-3 in gastric cancer tissue and its clinical significance.
Liu HQ; Song S; Wang JH; Zhang SL
Oncol Lett; 2011 Nov; 2(6):1319-1322. PubMed ID: 22848309
[TBL] [Abstract][Full Text] [Related]
20. TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association.
Xu P; Liu J; Sakaki-Yumoto M; Derynck R
Sci Signal; 2012 May; 5(222):ra34. PubMed ID: 22550340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
